Compare Intan Baru Prana Tbk. (IBFN) vs Indofarma Tbk. (INAF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intan Baru Prana Tbk. vs Indofarma Tbk. — how do they compare? Intan Baru Prana Tbk. trades at Rp63 (market cap 103.18B, 799.4K 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: Indofarma Tbk. is far larger — about 3.8× Intan Baru Prana Tbk.'s market cap. Which is the better fit depends on your goals.
| IBFN | INAF | |
|---|---|---|
Market Cap | 103.18B | 390.51B |
Volume | 799.4K | — |
Lot | 7.99K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intan Baru Prana Tbk.
PT Intan Baruprana Finance Tbk (the Company) was established based on Notarial Deed No. 19 dated September 4, 1991 and amended by Notarial Deed No. 121 dated June 16, 1993 of Esther Daniar Iskandar, S.H., notary in Jakarta. The Company started its commercial operations in 1997. The Company is part of the Intraco Penta group of companies.
Read more on IBFN →About Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →
